Bexarotene/mogamulizumabPsoriasis vulgaris exacerbation and lack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2021年 / 1877卷 / 1期

关键词：

D O I：

10.1007/s40278-021-03642-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：72 / 72

相关论文

共 50 条

[31] AntineoplasticsPneumonitis and lack of efficacy: case report
Reactions Weekly, 2024, 2024 (1) : 49 - 49
[32] AntineoplasticsAnaemia and lack of efficacy: case report
Reactions Weekly, 2023, 1950 (1) : 43 - 43
[33] ImmunosuppressantsInfections and lack of efficacy: case report
Reactions Weekly, 2023, 1938 (1) : 728 - 728
[34] AntineoplasticsFatigue and lack of efficacy: case report
Reactions Weekly, 2023, 1984 (1) : 66 - 66
[35] OctreotideAsystole and lack of efficacy: case report
Reactions Weekly, 2022, 1929 (1) : 512 - 512
[36] VismodegibFatigue and lack of efficacy: case report
Reactions Weekly, 2024, 2036 (1) : 461 - 461
[37] ImmunosuppressantsHepatotoxicity and lack of efficacy: case report
Reactions Weekly, 2022, 1908 (1) : 287 - 287
[38] PlasmaHypernatraemia and lack of efficacy: case report
Reactions Weekly, 2023, 1958 (1) : 432 - 432
[39] ImmunosuppressantsArteriolopathy and lack of efficacy : case report
Reactions Weekly, 2024, 2019 (1) : 218 - 218
[40] DurvalumabPneumonitis and lack of efficacy: case report
Reactions Weekly, 2023, 1985 (1) : 208 - 208

← 1 2 3 4 5 →